Showing results (21-30 of 678) with videos related to
Sort By:
Pageof 68
Future Oncology (London, England)|June 11, 2016
Pomalidomide in the management of relapsed multiple myelomaCyrille Touzeau, Philippe MoreauExpert Opinion on Biological Therapy|April 25, 2017
Daratumumab for the treatment of multiple myelomaCyrille Touzeau, Philippe MoreauClinical Lymphoma & Myeloma|October 20, 2005
Evolving role of stem cell transplantation in multiple myelomaJean-Luc Harousseau, Philippe MoreauJournal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
Role of bone marrow transplantation in the disease pathway of myelomaJean-Luc Harousseau, Philippe MoreauLeukemia Research|November 27, 2012
Optimizing therapy for transplant-eligible patients with newly diagnosed multiple myelomaPhilippe Moreau, Sergio A GiraltBlood Reviews|June 14, 2008
Frontline treatment of multiple myeloma in elderly patientsPhilippe Moreau, Cyrille Hulin, Thierry FaconBlood|April 4, 2015
Frontline therapy of multiple myelomaPhilippe Moreau, Michel Attal, Thierry FaconExpert Review of Anticancer Therapy|October 14, 2020
Monoclonal antibodies as an addition to current myeloma therapy strategiesMaxime Jullien, Cyrille Touzeau, Philippe MoreauHematology/Oncology Clinics of North America|September 13, 2014
Frontline Therapy for Patients with Multiple Myeloma not Eligible for Stem Cell TransplantationPhilippe Moreau, Cyrille Hulin, Thierry FaconOncotargets and Therapy|August 15, 2019
Update on elotuzumab for the treatment of relapsed/refractory multiple myeloma: patients' selection and perspectiveSabrina Trudel, Philippe Moreau, Cyrille TouzeauPageof 68